Dysregulated renin-AngioteNsin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice

Shock

Volumn 40, Issue 5, 2013, Pages 420-429

  Chen, Li Nan ^a   Yang, Xiu Hong ^a   Nissen, Daniel H ^a   Chen, Yan Yan ^a   Wang, Li Jun ^a   Wang, Jian Hui ^a   Gao, Jun Ling ^a   Zhang, Lian Yuan ^a  

^a HEBEI UNITED UNIVERSITY   (China)

Author keywords

ischemia reperfusion; remote acute lung injury; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYANOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE INSERTION; GENOTYPE; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; LISTLESSNESS; LOSS OF APPETITE; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MICROSCOPY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVERSE TRANSCRIPTION; TELANGIECTASIA; TIME; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANGIOTENSIN I; ANIMALS; GENE EXPRESSION REGULATION; GENOTYPE; HINDLIMB; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SIZE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84887028245     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182a6953e     Document Type: Article

References (37)

1. Kao MC, Jan WC, Tsai PS, Wang TY, Huang CJ: Magnesium sulfate mitigates lung injury induced by bilateral lower limb ischemia-reperfusion in rats. J Surg Res 171(1):e97-e106, 2011.
2. Yang XH, Wang YH, Wang JJ, Liu YC, Deng W, Qin C, Gao JL, Zhang LY: Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model. Peptides 36(1):60-70, 2012.
3. Shen L, Mo H, Cai L, Kong T, Zheng W, Ye J, Qi J, Xiao Z: Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock 31(5):500-506, 2009.
4. de Man FS, Tu L, Handoko ML, Rain S, Ruiter G, François C, Schalij I, Dorfmüller P, Simonneau G, Fadel E, et al.: Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 186(8):780-789, 2012.
5. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, et al.: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112-116, 2005.
6. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chappell MC: Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 55:166-171, 2010.
7. Wösten-van Asperen RM, Lutter R, Specht PA, van Woensel JB, van der Loos CM, Florquin S, Lachmann B, Bos AP: Ventilator-induced inflammatory response in LPS-exposed rat lung is mediated by angiotensin-converting enzyme. Am J Pathol 176(5):2219-2227, 2010.
8. Wösten-van Asperen RM, Lutter R, Specht PA, Moll GN, van Woensel JB, van der Loos CM, van Goor H, Kamilic J, Florquin S, Bos AP: Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 225 (4):618-627, 2011.
9. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T: Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 37(2):776-777, 2009.
10. Asmussen S, Bartha E, Olah G, Sbrana E, Rehberg SW, Yamamoto Y, Enkhbaatar P, Hawkins HK, Ito H, Cox RA, et al.: The Angiotensin-converting enzyme inhibitor captopril inhibits poly(ADP-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury. Shock 36(4):402-409, 2011.
11. He X, Han B, Mura M, Xia S, Wang S, Ma T, Liu M, Liu Z: Angiotensin-converting enzyme inhibitor captopril prevents oleic acidYinduced severe acute lung injury in rats. Shock 28(1):106-111, 2007.
12. Rey-Parra GJ, Vadivel A, Coltan L, Hall A, Eaton F, Schuster M, Loibner H, Penninger JM, Kassiri Z, Oudit GY, et al.: Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J Mol Med (Berl) 90(6):637-647, 2012.
13. Mikawa K, Nishina K, Takao Y, Obara H: ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg 97(6):1751-1755, 2003.
14. Nguyen Dinh Cat A, Touyz RM: A new look at the renin-angiotensin systemV focusing on the vascular system. Peptides 32(10):2141-2150, 2011.
15. Shahid M: The angiotensin-converting enzyme 2-angiotensin-(1-7) axis: the other side of the renin-angiotensin system. Exp Physiol 96(10):987-988, 2011.
16. Kaparianos A, Argyropoulou E: Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the patho-genesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem 18(23):3506-3515, 2011.
17. Wong MH, Chapin OC, Johnson MD: LPS-stimulated cytokine production in type I cells is modulated by the renin-angiotensin system. Am J Respir Cell Mol Biol 46(5):641-650, 2012.
18. Yang J, Tan Y, Zhao F, Ma Z, Wang Y, Zheng S, Epstein PN, Yu J, Yin X, Zheng Y, et al.: Angiotensin II plays a critical role in diabetic pulmonary fi-brosis most likely via activation of NADPH oxidase-mediated nitrosative damage. Am J Physiol Endocrinol Metab 301(1):E132-E144, 2011.
19. Uhal BD, Li X, Xue A, Gao X, Abdul-Hafez A: Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am J Physiol Lung Cell Mol Physiol 301(3):L269-L274, 2011.
20. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD: An-giotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 295(1): L178-L185, 2008.
21. Aneman A, Pettersson A, Eisenhofer G, Friberg P, Holm M, von Bothmer C, Fändriks L: Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock 8(5):378-384, 1997.
22. Laesser M, Fändriks L, Pettersson A, Ewert S, Aneman A: Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. Shock 14(4):471-477, 2000.
23. Zhang H, Sun GY: LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch Biochem Biophys 441(1):75-83, 2005.
24. Cao CS, Yin Q, Huang L, Zhan Z, Yang JB, Xiong HW: Effect of angiotensin II on the expression of aquaporin 1 in lung of rats following acute lung injury. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22(7):426-429, 2010.
25. Deng J, Wang DX, Deng W, Li CY, Tong J, Ma H: Regulation of alveolar fluid clearance and ENaC expression in lung by exogenous angiotensin II. Respir Physiol Neurobiol 181(1):53-61, 2012.
26. Deng J, Wang DX, Deng W, Li CY, Tong J: The effect of endogenous angio-tensin II on alveolar fluid clearance in rats with acute lung injury. Can Respir J 19(5):311-318, 2012.
27. Lee YH, Mungunsukh O, Tutino RL, Marquez AP, Day RM: Angiotensin-II- induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J Cell Sci 123(Pt 10):1634-1643, 2010.
28. Ferrario CM, Ahmad S, Joyner J, Varagic J: Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). Adv Pharmacol 59:197-233, 2010.
29. Liu L, Qiu HB, Yang Y, Wang L, Ding HM, Li HP: Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch Biochem Biophys 481(1):131-136, 2009.
30. Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM: Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32(3): 496-502, 1998.
31. Rentzsch B, Todiras M, Iliescu R, Popova E, Campos LA, Oliveira ML, Baltatu OC, Santos RA, Bader M: Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52(5):967-973, 2008.
32. Zhou MS, Jaimes EA, Raij L: Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens 23(9): 1737-1743, 2005.
33. Feliers D, Gorin Y, Ghosh-Choudhury G, Abboud HE, Kasinath BS: Angio-tensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol 290(4):F927-F936, 2006.
34. Yusof M, Kamada K, Gaskin FS, Korthuis RJ: Angiotensin II mediates postischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide. Am J Physiol Heart Circ Physiol 292(6):H3032-H3037, 2007.
35. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, Levitt KS, Oudit GY, Al-Omran M, Stewart DJ, et al.: Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 295(4):H1377-H1384, 2008.
36. Jin HY, Song B, Oudit GY, Davidge ST, Yu HM, Jiang YY, Gao PJ, Zhu DL, Ning G, Kassiri Z, et al.: ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production. PLoS One 7(6):e38502, 2012.
37. Kalea AZ, Batlle D: Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs 11(3):273-282, 2010.